Loading...

SLRX SALARIUS PHARMACEUTICALS INC Delisting Actions 8-K Filing

SLRS

SLRX

SALARIUS PHARMACEUTICALS INC

(SLRX)

2024 8-K

Show Summary

Summary

Merger of Equals

Equity Standard Compliance

Compliance Issues

Merger of Equals

Voluntary Delisting

Financial Update

Merger Agreement

Annual Meeting Results

Securities Agreement

Annual Meeting Notice

Stockholder Equity

Clinical Trial Closure

Clinical Trial Hold

Clinical Data Announcement

Reverse Stock Split

Departure of CEO and Change...

Financial Results

Annual Meeting Approval

Securities Purchase Agreement

Patent Issuance

External Links:

Salarius Pharmaceuticals, Inc. received notice from Nasdaq that it has been granted an additional 180-day grace period to regain compliance with the minimum bid price rule.

AI Assistant

SALARIUS PHARMACEUTICALS INC

2024

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.